PDCD1 and cancer: By leveraging gene expression data of samples from a cohort of cancer patients treated with anti-PD-1 therapy, we were able to identify genes and pathways that are both highly functionally associated with the MHC I pathway and deregulated in a given cancer type (Fig. 1b).